WHR
72
2
INTU
63
3
JBHT
70
2
NWSA
78
-19
GS
82
2
MTCH
40
14
VRTX
62
-6
QCOM
59
-4
TGT
49
5
RL
78
-5
DOV
71
2
GOOGL
64
5
ADBE
49
3
ABBV
33
-24
WFC
82
7
AMG
41
3
GT
64
-3
HRB
65
6
INTC
48
5
SO
55
-2
WHR
72
2
INTU
63
3
JBHT
70
2
NWSA
78
-19
GS
82
2
MTCH
40
14
VRTX
62
-6
QCOM
59
-4
TGT
49
5
RL
78
-5
DOV
71
2
GOOGL
64
5
ADBE
49
3
ABBV
33
-24
WFC
82
7
AMG
41
3
GT
64
-3
HRB
65
6
INTC
48
5
SO
55
-2
Financhill
Back

Zevra Therapeutics Stock Predictions

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
67

ZVRA
Zevra Therapeutics

Last Price:
8.55
Seasonality Move:
4.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Zevra Therapeutics Stock Forecast

  • Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 13.4% based on the past 9 years of stock performance.
  • Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
  • Is Zevra Therapeutics Stock Undervalued?
    The current Zevra Therapeutics [ZVRA] share price is $8.95. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Zevra Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 13.4% based on the past 9 years of stock performance.

Zevra Therapeutics Stock Rating

Buy
67
Zevra Therapeutics (ZVRA) is a Buy

Is Zevra Therapeutics overpriced?

  • Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

Zevra Therapeutics Stock Price History

Is ZVRA stock going to rise?

  • The current trend is moderately bullish and ZVRA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com

52-Week Data

52-Week High:
9.04
52-Week Low:
3.89

Prediction Charts

Market Cap:
470.93M
Price in USD:
8.95
Volume:
578.96K
Beta:
1.81

Technical Analysis

SMA50:
7.91
SMA100:
7.07
SMA200:
6.22
52-Wk Change:
115.66%

Stock Predictions

  • Is Zevra Therapeutics stock public?
    Yes, Zevra Therapeutics is a publicly traded company.
  • What is the Zevra Therapeutics stock quote today?
    The Zevra Therapeutics stock price is 8.95 USD today.
  • How to buy Zevra Therapeutics stock online?
    You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 8.30 8.01 8.34 7.93
Oct-24 7.99 7.90 8.09 7.85
Oct-25 7.92 7.75 8.02 7.67
Oct-28 7.78 8.05 8.15 7.71
Oct-29 8.10 8.26 8.28 7.97
Oct-30 8.17 8.43 8.58 8.11
Oct-31 8.38 8.16 8.53 8.14
Nov-1 8.17 8.40 8.66 8.17
Nov-4 8.32 8.55 8.67 8.22
Nov-5 8.54 8.61 8.65 8.26
Nov-6 8.70 8.80 8.91 8.60
Nov-7 8.88 8.81 9.03 8.67
Nov-8 8.81 9.00 9.04 8.65
Nov-11 9.02 8.95 9.04 8.76

Zevra Therapeutics Earnings

Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Zevra Therapeutics Forecast Revenue Growth

Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $1.26 per share.

* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.